Gene Therapy Could Make Cancer Care More Unequal, and This Map Shows Why

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

External News Details
Media
  • Aaron Levine Aaron Levine
    (image/jpeg)

Aaron Levine, associate professor in the Georgia Tech School of Public Policy, was quoted in the MIT Technology Review, January 12, article, “Gene Therapy Could Make Cancer Care More Unequal, and This Map Shows Why.” The School of Public Policy is a unit in Georgia Tech’s Ivan Allen College of Liberal Arts.

Excerpt:

Many patients have had remarkable recoveries, but they can also suffer toxic and sometimes deadly side effects. Aaron Levine at the Georgia Tech School of Public Policy, who has studied the ethics of CAR-T cell therapies, says these side effects will likely be the biggest obstacle to making the therapies more widely available, “as only a small number of physicians and medical teams are prepared to address them.”

For the full article, visit the MIT Technology Review website.

Additional Information

Groups

Ivan Allen College of Liberal Arts

Categories
Institute and Campus
Keywords
recoveries, toxic, Ethics, CAR-T
Status
  • Created By: ralu3
  • Workflow Status: Published
  • Created On: Jan 22, 2018 - 11:33am
  • Last Updated: Jan 22, 2018 - 11:56am